{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:44:37Z","timestamp":1790419477652,"version":"4.1.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To systematically review the available literature on the pharmacological management of agitation and\/or aggression in patients with traumatic brain injury (TBI), synthesize the available data, and provide guidelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Systematic review of systematic reviews.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main Measures:<\/jats:title>\n            <jats:p>A literature review of the following websites was performed looking for systematic reviews on the treatment of agitation and\/or aggression among patients with TBI: PubMed, CINAHL, DynaMed, Health Business Elite, and EBSCO (Psychology and behavioral sciences collection). Two researchers independently assessed articles for meeting inclusion\/exclusion criteria. Data were extracted on year of publication, reviewed databases, dates of coverage, search limitations, pharmacological agents of interest, and a list of all controlled studies included. The included controlled studies were then examined to determine potential reasons for any difference in recommendations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The literature review led to 187 citations and 67 unique publications after removing the duplicates. Following review of the title\/abstracts and full texts, a total of 11 systematic reviews were included. The systematic reviews evaluated the evidence for safety and efficacy of the following medications: amantadine, amphetamines, methylphenidate, antiepileptics, atypical and typical antipsychotics, benzodiazepines, \u03b2-blockers, and sertraline.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>On the basis of the results of this literature review, the authors recommend avoiding benzodiazepines and haloperidol for treating agitation and\/or aggression in the context of TBI. Atypical antipsychotics (olanzapine in particular) can be considered as practical alternatives for the as-needed management of agitation and\/or aggression in lieu of benzodiazepines and haloperidol. Amantadine, \u03b2-blockers (propranolol and pindolol), antiepileptics, and methylphenidate can be considered for scheduled treatment of agitation and\/or aggression in patients with TBI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/htr.0000000000000656","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T18:47:06Z","timestamp":1614797226000},"page":"E262-E283","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":43,"title":["Pharmacological Treatment of Agitation and\/or Aggression in Patients With Traumatic Brain Injury: A Systematic Review of Reviews"],"prefix":"10.1097","volume":"36","author":[{"given":"Elham","family":"Rahmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia M.","family":"Lemelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Samarbafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita S.","family":"Kablinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"R2-20250529","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/HTR.0b013e3181ccc8b4","article-title":"The epidemiology of traumatic brain injury","volume":"25","author":"Corrigan","year":"2010","journal-title":"J Head Trauma Rehabil"},{"key":"R3-20250529","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(17)30371-X","article-title":"Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research","volume":"16","author":"Maas","year":"2017","journal-title":"Lancet Neurol"},{"key":"R4-20250529","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/026990500421895","article-title":"Acute behavioural disturbances related to imaging studies and outcome in mild to moderate head injury","volume":"14","author":"van der Naalt","year":"2000","journal-title":"Brain Inj"},{"key":"R5-20250529","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.PHM.0000140790.30468.F4","article-title":"Gender differences in agitation after traumatic brain injury","volume":"83","author":"Kadyan","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"R6-20250529","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/02699050600832684","article-title":"Objective and behavioural assessment of the emergence from posttraumatic amnesia (PTA)","volume":"20","author":"Weir","year":"2006","journal-title":"Brain Inj"},{"key":"R7-20250529","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/02699052.2013.873142","article-title":"Agitation after traumatic brain injury and predictors of outcome","volume":"28","author":"Singh","year":"2014","journal-title":"Brain Inj"},{"key":"R8-20250529","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/02699050601049114","article-title":"Agitation following traumatic brain injury: an Australian sample","volume":"20","author":"Nott","year":"2006","journal-title":"Brain Inj"},{"key":"R9-20250529","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00002060-200109000-00002","article-title":"Role of agitation in prediction of outcomes after traumatic brain injury","volume":"80","author":"Bogner","year":"2001","journal-title":"Am J Phys Med Rehabil"},{"key":"R10-20250529","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/rnj.82","article-title":"Occurrence and severity of agitated behavior after severe traumatic brain injury","volume":"38","author":"Wolffbrandt","year":"2013","journal-title":"Rehabil Nurs"},{"key":"R11-20250529","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1176\/appi.psy.50.3.198","article-title":"Neuropsychiatric problems after traumatic brain injury: unraveling the silent epidemic","volume":"50","author":"Vaishnavi","year":"2009","journal-title":"Psychosomatics"},{"key":"R12-20250529","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2147\/NDT.S80457","article-title":"Diagnostic and treatment challenges in traumatic brain injury patients with severe neuropsychiatric symptoms: insights into psychiatric practice","volume":"11","author":"Lauterbach","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"R13-20250529","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.rehab.2015.11.001","article-title":"Care management of the agitation or aggressiveness crisis in patients with TBI. Systematic review of the literature and practice recommendations","volume":"59","author":"Luaut\u00e9","year":"2016","journal-title":"Ann Phys Rehabil Med"},{"issue":"1","key":"R14-20250529","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rehab.2015.10.003","article-title":"Drugs for behavior disorders after traumatic brain injury: systematic review and expert consensus leading to French recommendations for good practice","volume":"59","author":"Plantier","year":"2016","journal-title":"Ann Phys Rehabil Med"},{"key":"R15-20250529","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3389\/fneur.2019.01169","article-title":"The efficacy and harms of pharmacological interventions for aggression after traumatic brain injury-systematic review","volume":"10","author":"Hicks","year":"2019","journal-title":"Front Neurol"},{"issue":"3","key":"R16-20250529","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/02699052.2017.1419377","article-title":"Pharmacological management of agitation among individuals with moderate to severe acquired brain injury: a systematic review","volume":"32","author":"Mehta","year":"2018","journal-title":"Brain Inj"},{"issue":"1","key":"R17-20250529","first-page":"28","article-title":"Efficacy and tolerability of antipsychotics in treatment of agitation and aggression following traumatic brain injury (TBI): systematic review of clinical trials","volume":"30","author":"Mohamed Ali","year":"2015","journal-title":"Eur Psychiatry"},{"issue":"9","key":"R18-20250529","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1080\/02699052.2019.1631482","article-title":"Efficacy of amantadine on behavioural problems due to acquired brain injury: a systematic review","volume":"33","author":"Ter Mors","year":"2019","journal-title":"Brain Inj"},{"issue":"2","key":"R19-20250529","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.psym.2018.11.009","article-title":"Acute pharmacological management of behavioral and emotional dysregulation following a traumatic brain injury: a systematic review of the literature","volume":"60","author":"Nash","year":"2019","journal-title":"Psychosomatics"},{"issue":"6","key":"R20-20250529","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/neu.2015.17","article-title":"The effectiveness of dopamine agonists for treatment of neuropsychiatric symptoms post-brain injury and stroke","volume":"27","author":"Sami","year":"2015","journal-title":"Acta Neuropsychiatr"},{"issue":"4","key":"R21-20250529","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/JTN.0000000000000138","article-title":"Amantadine to treat cognitive dysfunction in moderate to severe traumatic brain injury","volume":"22","author":"Stelmaschuk","year":"2015","journal-title":"J Trauma Nurs"},{"issue":"6","key":"R22-20250529","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/JCP.0b013e318235f4ac","article-title":"Impact of pharmacological treatments on cognitive and behavioral outcome in the postacute stages of adult traumatic brain injury: a meta-analysis","volume":"31","author":"Wheaton","year":"2011","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"R23-20250529","doi-asserted-by":"crossref","first-page":"e029604","DOI":"10.1136\/bmjopen-2019-029604","article-title":"Pharmacological interventions for agitated behaviours in patients with traumatic brain injury: a systematic review","volume":"9","author":"Williamson","year":"2019","journal-title":"BMJ Open"},{"issue":"10","key":"R24-20250529","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R26-20250529","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"R29-20250529","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/01.HTR.0000438116.56228.de","article-title":"Effectiveness of amantadine hydrochloride in the reduction of chronic traumatic brain injury irritability and aggression","volume":"29","author":"Hammond","year":"2014","journal-title":"J Head Trauma Rehabil"},{"key":"R30-20250529","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1089\/neu.2014.3803","article-title":"Amantadine effect on perceptions of irritability after traumatic brain injury: results of the Amantadine Irritability Multisite Study","volume":"32","author":"Hammond","year":"2015","journal-title":"J Neurotrauma"},{"key":"R31-20250529","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/HTR.0000000000000342","article-title":"Potential impact of amantadine on aggression in chronic traumatic brain injury","volume":"32","author":"Hammond","year":"2017","journal-title":"J Head Trauma Rehabil"},{"key":"R32-20250529","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/026990599121061","article-title":"Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study","volume":"13","author":"Schneider","year":"1999","journal-title":"Brain Inj"},{"key":"R33-20250529","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00001199-200208000-00004","article-title":"Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: A pilot double-blind randomized trial","volume":"17","author":"Meythaler","year":"2002","journal-title":"J Head Trauma Rehabil"},{"key":"R34-20250529","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1102609","article-title":"Placebo-controlled trial of amantadine for severe traumatic brain injury","volume":"366","author":"Giacino","year":"2012","journal-title":"N Engl J Med"},{"key":"R35-20250529","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/WNF.0000000000000242","article-title":"Effect of amantadine on agitation in critically ill patients with traumatic brain injury","volume":"40","author":"Gramish","year":"2017","journal-title":"Clin Neuropharmacol"},{"key":"R36-20250529","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3109\/02699052.2014.930179","article-title":"Traumatic brain injury related attention deficits: treatment outcomes with lisdexamfetamine dimesylate (Vyvanse)","volume":"28","author":"Tramontana","year":"2014","journal-title":"Brain Inj"},{"issue":"4","key":"R37-20250529","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/jnr.24102","article-title":"Effects of dextroamphetamine in subacute traumatic brain injury: a randomized, placebo-controlled pilot study","volume":"96","author":"Hart","year":"2018","journal-title":"J Neurosci Res"},{"key":"R38-20250529","first-page":"153","article-title":"Effect of methylphenidate on brain injury related anger","volume":"74","author":"Mooney","year":"1993","journal-title":"Archives Phys Med Rehabil"},{"key":"R39-20250529","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/02699059309034959","article-title":"A double-blind controlled study of methylphenidate treatment in closed head injury","volume":"7","author":"Speech","year":"1993","journal-title":"Brain Inj"},{"key":"R40-20250529","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/02699052.2013.865267","article-title":"Evaluation of dosage, safety and effects of methylphenidate on posttraumatic brain injury symptoms with a focus on mental fatigue and pain","volume":"28","author":"Johansson","year":"2014","journal-title":"Brain Inj"},{"key":"R42-20250529","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.jcp.0000186739.22395.6b","article-title":"Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial","volume":"25","author":"Mattes","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R43-20250529","first-page":"22","article-title":"Control de la agresividad con olanzapina en pacientes post tec [Aggressiveness control using olanzapine in post-TBI patients]","volume":"31","author":"Maturana Waidele","year":"2009","journal-title":"Cienc Trab"},{"key":"R44-20250529","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.ccm.0000474980.38145.7b","article-title":"1149: The effect of antipsychotic use posttraumatic brain injury on duration of post-traumatic amnesia","volume":"43","author":"Kooda","year":"2015","journal-title":"Crit Care Med"},{"key":"R45-20250529","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/02699050600743972","article-title":"The impact of acute care medications on rehabilitation outcome after traumatic brain injury","volume":"20","author":"Mysiw","year":"2006","journal-title":"Brain Inj"},{"key":"R46-20250529","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00005053-198605000-00005","article-title":"Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study","volume":"174","author":"Greendyke","year":"1986","journal-title":"J Nerv Ment Dis"},{"key":"R47-20250529","first-page":"423","article-title":"Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study","volume":"47","author":"Greendyke","year":"1986","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"R48-20250529","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0033-3182(89)72297-0","article-title":"Treatment of behavioral problems with pindolol","volume":"30","author":"Greendyke","year":"1989","journal-title":"Psychosomatics"},{"key":"R49-20250529","first-page":"917","article-title":"The treatment of agitation during initial hospitalization after traumatic brain injury","volume":"73","author":"Brooke","year":"1992","journal-title":"Arch Phys Med Rehabil"},{"key":"R50-20250529","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1037\/a0012973","article-title":"Advanced regression methods for single-case designs: studying propranolol in the treatment for agitation associated with traumatic brain injury","volume":"53","author":"Brossart","year":"2008","journal-title":"Rehabil Psychol"},{"key":"R51-20250529","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/026990501750111274","article-title":"Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes","volume":"15","author":"Meythaler","year":"2001","journal-title":"Brain Inj"},{"key":"R52-20250529","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/HTR.0b013e3181d6c715","article-title":"Impact of early administration of sertraline on cognitive and behavioral recovery in the first year after moderate to severe traumatic brain injury","volume":"25","author":"Ba\u00f1os","year":"2010","journal-title":"J Head Trauma Rehabil"},{"key":"R53-20250529","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/HTR.0000000000000322","article-title":"Sertraline for major depression during the year following traumatic brain injury: a randomized controlled trial","volume":"32","author":"Fann","year":"2017","journal-title":"J Head Trauma Rehabil"},{"key":"R54-20250529","first-page":"30","article-title":"Agitation in closed head injury: haloperidol effects on rehabilitation outcome","volume":"66","author":"Rao","year":"1985","journal-title":"Arch Phys Med Rehabil"},{"key":"R55-20250529","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21767\/2471-8505.100023","article-title":"Haloperidol use in acute traumatic brain injury: a safety analysis","volume":"2","author":"Anderson","year":"2016","journal-title":"J Intensive Crit Care"},{"key":"R56-20250529","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.lfs.2008.08.007","article-title":"Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits","volume":"83","author":"Hoffman","year":"2008","journal-title":"Life Sci"},{"key":"R57-20250529","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neulet.2008.10.076","article-title":"Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injury","volume":"448","author":"Kline","year":"2008","journal-title":"Neurosci Lett"},{"key":"R58-20250529","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.CCM.0000256722.88854.C0","article-title":"Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain trauma","volume":"35","author":"Kline","year":"2007","journal-title":"Crit Care Med"},{"key":"R59-20250529","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1089\/neu.2014.3711","article-title":"Divergent long-term consequences of chronic treatment with haloperidol, risperidone, and bromocriptine on traumatic brain injury-induced cognitive deficits","volume":"32","author":"Phelps","year":"2015","journal-title":"J Neurotrauma"},{"key":"R60-20250529","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.PHM.0000091982.33232.CB","article-title":"Haloperidol, but not olanzapine, impairs cognitive performance after traumatic brain injury in rats","volume":"82","author":"Wilson","year":"2003","journal-title":"Am J Phys Med Rehabil"},{"issue":"7","key":"R61-20250529","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.neubiorev.2009.03.011","article-title":"Persistent cognitive dysfunction after traumatic brain injury: a dopamine hypothesis","volume":"33","author":"Bales","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"issue":"9","key":"R63-20250529","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0003-9993(97)90051-4","article-title":"Measurement and treatment of agitation following traumatic brain injury: II. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation","volume":"78","author":"Fugate","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"issue":"10","key":"R64-20250529","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/02699050701559558","article-title":"Pharmacological management of neurobehavioural sequelae of traumatic brain injury: a survey of current physiatric practice","volume":"21","author":"Francisco","year":"2007","journal-title":"Brain Inj"}],"container-title":["Journal of Head Trauma Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HTR.0000000000000656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:04:08Z","timestamp":1748527448000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HTR.0000000000000656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/htr.0000000000000656","relation":{},"ISSN":["0885-9701"],"issn-type":[{"value":"0885-9701","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,22]]}}}